Patients whose outside images were imported into their institutions' PACS were significantly less likely to undergo repeat imaging.
Importing outside images to the PACS reduces the rate of repeat imaging tests, lowering patient costs and exposure to radiation, according to a study published in the March issue ofAmerican Journal of Roentgenology.
Researchers from the University of California in San Francisco undertook a retrospective study looking at 267 patients who had undergone an abdominal CT or MRI scan at their institution or at another within four months before undergoing transarterial chemoembolization.
The researchers were looking at the availability of images from the other institutions to their institutions. They examined whether the images were on CD or film but not imported, which images were imported, and if no outside imaging was available at all.
Researchers found:
• If the patients’ outside images were not available, 72 percent of the patients had repeat imaging.
• If the patients’ outside images were available but not imported to the PACS, 52 percent had repeat imaging.
• If the patients’ outside images were imported to the PACS, 11 percent had repeat imaging.
• If the imaging was done at their institution, 13 percent of patients had repeat imaging.
“Patients whose outside images were imported were significantly less likely to undergo repeat imaging than were both the groups whose outside images were not imported,” the authors wrote.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.